About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5578118
Allelic
Composition
Tbc1d10ctm1.1Psou/Tbc1d10ctm1.2Psou
Cd79atm1(cre)Reth/Cd79a+
Genetic
Background
involves: 129S2/SvPas * BALB/c * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd79atm1(cre)Reth mutation (3 available); any Cd79a mutation (26 available)
Tbc1d10ctm1.1Psou mutation (1 available); any Tbc1d10c mutation (17 available)
Tbc1d10ctm1.2Psou mutation (1 available); any Tbc1d10c mutation (17 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• accelerated antigen-specific B cell response in vivo in response to ovalbumin
• increased anti-ovalbumin IgG titer after ovalbumin treatment
• CpG-DNA-treated mice exhibit renal IgG deposits unlike wild-type mice
• in ovalbumin-treated mice
• CpG-DNA-treated mice exhibit increased anti-double stranded DNA antibody levels and renal IgG deposits compared with control mice
• in CpG-DNA-treated mice
• however, untreated mice do not produce autoantibodies

hematopoietic system
• accelerated antigen-specific B cell response in vivo in response to ovalbumin
• increased anti-ovalbumin IgG titer after ovalbumin treatment
• CpG-DNA-treated mice exhibit renal IgG deposits unlike wild-type mice
• in ovalbumin-treated mice


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
07/22/2025
MGI 6.24
The Jackson Laboratory